Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
Cancer arises from the uncontrolled growth and division of cells, and is caused by the cooperation of mutations in DNA that activate genes that push cell division, and suppress natural anti-cancer mechanisms. Currently in the UK, around 275,000 people per year are diagnosed with cancer and, of these, around 150,000 die. For the 400 people who die each day from the disease, treatment is largely ineffective and offers at best an extension of life, rather than a cure.
Current anti-cancer therapies are primarily based on trying to inhibit cancer cell growth, causing cancer cells to die, or a combination of both. Frequently, initial treatments may appear to be successful, but the disease re-occurs at a later date. Understanding how this happens, and what controls the ability of cancer cells to spread throughout the body, is a crucial aspect of cancer research.
Recent advances in our understanding of cancer have revealed why many current treatments may be ineffective. Within any tumour, there may be many different kinds of cancer cell, only some of which are targeted by a particular treatment. Although a therapy may be successful in killing some of these sub-populations of cells, others survive and these then go on to kill the patient.
The discovery of normal adult stem cells, able to self-renew and regenerate damaged tissue, has led to the idea that cancer may either originate from adult stem cells or contain stem cell-like cells that are self renewing, resistant to therapy and able to seed new tumour growth. ‘Identifying the stem cell-like cells within cancers and understanding their properties will be crucial if effective anti-cancer therapies are to be developed’ says Colin Goding who works on melanoma, one of the most aggressive types of cancer. ‘Surprisingly, the work suggests that different populations of cancer cells within a tumour can switch back and forth between one type which divides rapidly but does not invade, and a stem cell-like cell that divides slowly but is highly metastatic.
OMICS Group through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS Group hosts over 350 leading-edge peer reviewed Open Access journals and has organised over 500 scientific conferences all over the world. OMICS Publishing Group journals have over 3.5 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 30000 eminent personalities and the rapid, quality and quick review processing. OMICS Group International Conferences make the perfect platform for global networking as it brings together renowned speakers and scientists across the globe to a most exciting and memorable scientific event filled with much enlightening interactive sessions, world class exhibitions and poster presentations. Now focusing on Diagnostic Imaging conference to provide a better platform for the Researchers, Doctors to share their views & knowledge.
The Global Cancer Conference & Medicare Summit, hosted by the OMICS Group. It was held during September 15-17, 2014 at Hyderabad, India. Generous response and active participation was received from the Editorial Board Members of OMICS Group Journals as well as from scientists, researchers and leaders from cancer related industries, government organizations, students who made this conference as one of most successful and productive events in 2014 from OMICS Group.
Conferences
Biology and Treatment of Metastatic Cancers
Venue: Mazagan Beach Resort
Location: El Jadida, Morocco
BEGINS: Sep 23, 2014Ends Sep 26, 2014
EMBO EMBL Symposia Epithelia The Building Blocks of Multicellularity
Venue: EMBL
Location: Heidelberg, Germany
BEGINS: Aug 27, 2014Ends Aug 30, 2014
EMBO EMBL Symposium Tumour Microenvironment and Signalling
Venue: EMBL
Location: Heidelberg, Germany
BEGINS: May 07, 2014Ends May 10, 2014
Washington BioLeaders Forum 2014
Venue: Grand Hyatt Washington
Location: Washington, Washington, United States
BEGINS: Jan 27, 2014 09:00 AM Ends Jan 29, 2014 05:30 PM
Keystone Symposia Sensing and Signaling of Hypoxia - Interfaces with Biology and Medicine (A1)
Venue: Beaver Run Resort & Conference Center
Location: Breckenridge, Colorado, United States
BEGINS: Jan 07, 2014Ends Jan 12, 2014
EACR-Sponsored, 2nd Anticancer Agents Congress Targeting Cancer Stem Cell
Venue: IC HOTELS SANTAI FAMILY RESORT
Location: Antalya, Turkey
BEGINS: Nov 21, 2013 Ends Nov 24, 2013
The Second International Conference Nanotechnology, Biotechnology and Spectroscopy Tools
Venue: Cataract pyramids hotel
Location: Giza, Egypt
BEGINS: Oct 25, 2013 08:30 AM Ends Oct 27, 2013 06:00 PM
2nd Protein Kinases Drug Design Conference
Venue: Paradise Point Resort & Spa
Location: San Diego, California, United States
BEGINS: Oct 23, 2013 Ends Oct 25, 2013
Companies
Bavarian Nordic, Mountain View, CA
Juvaris, Pleasanton, CA
PaxVax, San Diego, CA
MSD, Ireland
Genocea Bioscience, Cambridge, MA
This page will be updated regularly.
This page was last updated on November 22, 2024
